DRIO PE Ratio & Valuation, Is DRIO Overvalued

Historical Valuation

DarioHealth Corp (DRIO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.79 is considered Undervalued compared with the five-year average of -2.05. The fair price of DarioHealth Corp (DRIO) is between 31.05 to 48.77 according to relative valuation method. Compared to the current price of 9.40 USD , DarioHealth Corp By Undervalued By 69.73%.

Relative Value

Fair Zone

31.05-48.77

Current Price：9.40

69.73%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is DarioHealth Corp (DRIO) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

DarioHealth Corp (DRIO) has a current Price-to-Book (P/B) ratio of 0.95. Compared to its 3-year average P/B ratio of 0.74, the current P/B ratio is approximately 28.35% higher. Relative to its 5-year average P/B ratio of 1.22, the current P/B ratio is about -22.00% higher. DarioHealth Corp (DRIO) has a Forward Free Cash Flow (FCF) yield of approximately -37.87%. Compared to its 3-year average FCF yield of -88.68%, the current FCF yield is approximately -57.30% lower. Relative to its 5-year average FCF yield of -64.66%, the current FCF yield is about -41.44% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for DRIO competitors is 38.06, providing a benchmark for relative valuation. DarioHealth Corp Corp (DRIO.O) exhibits a P/S ratio of 2.79, which is -92.66% above the industry average. Given its robust revenue growth of -32.55%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of DRIO increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of DRIO in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is DRIO currently overvalued or undervalued?

What is DarioHealth Corp (DRIO) fair value?

DRIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of DarioHealth Corp (DRIO) is between 31.05 to 48.77 according to relative valuation method.

How does DRIO's valuation metrics compare to the industry average?

The average P/S ratio for DRIO's competitors is 38.06, providing a benchmark for relative valuation. DarioHealth Corp Corp (DRIO) exhibits a P/S ratio of 2.79, which is -92.66% above the industry average. Given its robust revenue growth of -32.55%, this premium appears unsustainable.

What is the current P/B ratio for DarioHealth Corp (DRIO) as of Mar 05 2026?

As of Mar 05 2026, DarioHealth Corp (DRIO) has a P/B ratio of 0.95. This indicates that the market values DRIO at 0.95 times its book value.

What is the current FCF Yield for DarioHealth Corp (DRIO) as of Mar 05 2026?

As of Mar 05 2026, DarioHealth Corp (DRIO) has a FCF Yield of -37.87%. This means that for every dollar of DarioHealth Corp's market capitalization, the company generates -37.87 cents in free cash flow.

What is the current Forward P/E ratio for DarioHealth Corp (DRIO) as of Mar 05 2026?

As of Mar 05 2026, DarioHealth Corp (DRIO) has a Forward P/E ratio of -0.79. This means the market is willing to pay $-0.79 for every dollar of DarioHealth Corp's expected earnings over the next 12 months.

What is the current Forward P/S ratio for DarioHealth Corp (DRIO) as of Mar 05 2026?

As of Mar 05 2026, DarioHealth Corp (DRIO) has a Forward P/S ratio of 2.79. This means the market is valuing DRIO at $2.79 for every dollar of expected revenue over the next 12 months.

DRIO Valuation